DNA-based assay for calorimetric determination and quantitation of protein concentrations in pure or mixed solutions
DNA-based assay for calorimetric determination and quantitation of protein concentrations in pure or mixed solutions
批准号:
10547595
负责人:
Matthew Walter Eskew
金额:
$25.86万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-06 至 2024-01-05
关键词:
2019-nCoVACE2AddressAntibodiesBiologicalBiological AssayBiological ProductsBuffersCharacteristicsClinical TrialsCollaborationsComplexComplex MixturesConsumptionCulture MediaDNADiagnostic Reagent KitsDifferential Scanning CalorimetryEngineeringEnvironmentEquipmentFeedbackFluorescenceGlassIn VitroIndividualInstructionLaboratoriesLibrariesMass Spectrum AnalysisMeasurementMethodsModificationMolecular TargetNucleocapsid ProteinsOutcomePainPeptide antibodiesPeptidesPharmaceutical PreparationsPhaseProcessProductionPropertyProtein AnalysisProteinsReagentResourcesSamplingScanningSchemeSurveysSystemTechniquesTestingTherapeuticThermodynamicsTimeVial deviceViral ProteinsWorkbasecostdata reductiondesignexperienceinstrumentmeltingnovelnovel therapeuticspreventprotein structureresponsescreeningvalidation studies
中文摘要
摘要
英文摘要
Abstract
An attractive feature of using in vitro expression systems to generate biological compounds is the
capability to produce a wide variety of compounds (proteins, peptides, antibodies) on various scales, in a
cheap and rapid manner. Current methods to analyze any of these produced compounds require
purification which poses a major drawback for working with products derived from expression systems.
For example, a moderately abundant (soluble) protein can require 27 individual steps over four days to
purify; a significant amount of time and expense to screen a single protein. Screening a library of potential
biological compounds for therapeutic value, requires many purification steps for each compound before
any analysis can be performed. This includes measurements as simple as determination of the mass of
the produced biological compounds. To this end we have developed a unique DNA-based scheme using
differential scanning calorimetry for determination of the masses of biological compounds in both purified
and mixed media. Uniquely, our probes are universally applicable to a wide range of biological compounds
enabling mass quantification prior to purification. This advance allows for initial analysis of biologics early
in the production process, lowering associated time requirements and resource costs. An added benefit
is the possibility to supplant the numerous mass analysis kits currently on the market that rely on
colorimetric or fluorescent methods. These methods are highly specific to the types of compounds
assayed and have limitations preventing universal applicability. Our product offers a superior advantage
of existing methods. In this project we plan to screen a library of biologically expressed SARS-CoV-2 spike
and nucleocapsid proteins generated by our commercial collaborator. The aim of this work is to evaluate
whether our assay is capable of predicting protein yields from their expression systems solely from a mass
determination of their unpurified samples. Additionally, we will use our assay to verify the protein
structure before and after purification.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
AURKA介导ACE2磷酸化修饰调控内皮细胞衰老在低氧性肺动脉高压中的作用及机制研究
-
批准号:82570085
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:沈慧
-
依托单位:
牛蒡叶倍半萜成分群激活ACE2/Ang1-7/MasR轴调控血管内皮—周细胞互作促缺血性脑卒中血管正常化机制研究
-
批准号:82404910
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:郝单丽
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
ACE2通过AMPK/SIRT3调控线粒体代谢改善盐敏感性高血压肾脏纤维化的机制
-
批准号:82460087
-
项目类别:地区科学基金项目
-
资助金额:33.00万元
-
批准年份:2024
-
负责人:赵宇
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位: